NanoSphere Health Sciences Inc.
NSHSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $23 | $27 | $60 |
| G&A Expenses | $84 | $107 | $257 | $297 |
| SG&A Expenses | $160 | $197 | $257 | $297 |
| Sales & Mktg Exp. | $75 | $90 | $0 | $0 |
| Other Operating Expenses | -$160 | $0 | -$11 | $27 |
| Operating Expenses | $0 | $220 | $273 | $383 |
| Operating Income | -$169 | -$220 | -$263 | -$355 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $426 | -$8 | -$19 | -$1 |
| Pre-Tax Income | $0 | -$228 | -$282 | -$356 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | $0 | -$228 | -$282 | -$356 |
| % Margin | – | – | – | – |
| EPS | 0.024 | -0.022 | -0.027 | -0.052 |
| % Growth | 209.9% | 19% | 47.1% | – |
| EPS Diluted | 0.024 | -0.022 | -0.027 | -0.052 |
| Weighted Avg Shares Out | 10,275 | 10,275 | 10,275 | 6,815 |
| Weighted Avg Shares Out Dil | 10,275 | 10,275 | 10,275 | 6,815 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $0 | $0 | $0 |
| Depreciation & Amortization | $169 | $220 | $263 | $14 |
| EBITDA | $252 | -$12 | -$271 | -$341 |
| % Margin | – | – | – | – |